Back
Viking Therapeutics Stock Price Chart

Mode Mobile Could be Next in Line
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45
VKTX
Viking Therapeutics
Last Price:
$23.92
Seasonality Move:
14.71%
7 Day Trial
ALL ACCESS PASS
$
7

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Viking Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.76 | Buy |
20-day SMA: | 24.41 | Sell |
50-day SMA: | 27.65 | Sell |
200-day SMA: | 47.91 | Sell |
8-day EMA: | 23.37 | Buy |
20-day EMA: | 24.44 | Sell |
50-day EMA: | 28.23 | Sell |
200-day EMA: | 41.18 | Sell |
Viking Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.52 | Sell |
Relative Strength Index (14 RSI): | 46.06 | Sell |
Chaikin Money Flow: | 4414285 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.41 - 28.53) | Sell |
Bollinger Bands (100): | (25.8 - 44.6) | Sell |
Viking Therapeutics Technical Analysis
Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Viking Therapeutics Stock
Is Viking Therapeutics Stock a Buy?
-
Viking Therapeutics share price is 23.94 while VKTX 8-day simple moving average is 22.76, which is a Buy signal.
-
The stock price of VKTX is 23.94 while Viking Therapeutics 20-day SMA is 24.41, which makes it a Sell.
-
Viking Therapeutics 50-day simple moving average is 27.65 while VKTX share price is 23.94, making it a Sell technically.
-
VKTX stock price is 23.94 and Viking Therapeutics 200-day simple moving average is 47.91, creating a Sell signal.
VKTX Technical Analysis vs Fundamental Analysis
Sell
45
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy or a Sell?
-
Viking Therapeutics stock is rated a SellThe current Viking Therapeutics [VKTX] share price is $23.94. The Score for VKTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Viking Therapeutics Stock Info
Market Cap:
2.7B
Price in USD:
23.94
Share Volume:
5M
Viking Therapeutics 52-Week Range
52-Week High:
81.86
52-Week Low:
18.92
Sell
45
Viking Therapeutics (VKTX)
is a Sell
Viking Therapeutics Share Price Forecast
-
What is the Viking Therapeutics stock price today?The Viking Therapeutics stock price is 23.94 USD today.
-
Will VKTX stock go up or go down?Viking Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Viking Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viking Therapeutics is overvalued.
Is Viking Therapeutics Stock a Buy?
-
Viking Therapeutics share price is 23.94 while VKTX 8-day exponential moving average is 23.37, which is a Buy signal.
-
The stock price of VKTX is 23.94 while Viking Therapeutics 20-day EMA is 24.44, which makes it a Sell.
-
Viking Therapeutics 50-day exponential moving average is 28.23 while VKTX share price is 23.94, making it a Sell technically.
-
VKTX stock price is 23.94 and Viking Therapeutics 200-day simple moving average is 41.18, creating a Sell signal.
Fundamental Analysis of Viking Therapeutics
Is Viking Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.57 per share, and a decrease next year of $0.54 per share.
Technical Analysis of Viking Therapeutics
Should I short Viking Therapeutics stock?
-
VKTX Moving Average Covergence Divergence (MACD) indicator is -1.52, suggesting Viking Therapeutics is a Sell
-
Viking Therapeutics Relative Strength Index (RSI) is 46.06, which suggest Viking Therapeutics is oversold
-
The Bollinger Bands (25) for Viking Therapeutics is (22.41 - 28.53), which suggest Viking Therapeutics is a Sell
-
The Bollinger Bands (100) for Viking Therapeutics is (25.8 - 44.6), which suggest Viking Therapeutics is a Sell
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.